Articles

Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia

Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
ICGEB, Trieste, Italy
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Lab of Cancer Immunogenetics, Department of Medical Sciences, University of Turin, Turin, Italy;
Haematologica Early view Apr 16, 2020 https://doi.org/10.3324/haematol.2019.242016